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Abstract: Normal left ventricular (LV) mass and geometry is required for optimal LV functioning. Abnormalities in either result in increased morbidity and mortality. The adducing 1 (alpha) gene (ADD1) Gly460Trp polymorphism has
been associated with high blood pressure and increased plasma volume, both predictors of LV mass and function. In
this cross-sectional study, we evaluate the association between this polymorphism and LV mass and geometry. LV
mass, relative wall thickness (RWT), and systolic and diastolic parameters were measured using echocardiography in
3483 African American and Caucasian subjects from the Hypertension Genetic Epidemiology Network (HyperGEN).
Analysis of covariance was used to estimate the polymorphism’s association with echocardiograph parameters, stratified by race. The model was adjusted for age, diastolic and systolic blood pressure, glomerular filtration rate, smoking, low and high density lipoprotein cholesterol, urinary sodium, and body mass index. In Caucasians, the Trp allele
was associated with higher ejection fraction (EF) (P = .02), fractional shortening (FS) (P = .02), and RWT (P = .03). In
African Americans, the Trp allele was negatively associated with RWT (P = .02), but no association was found with EF
(P = .08) or FS (P = .09). The polymorphism was not associated with diastolic function parameters in either racial
group. We found no association of ADD1 Gly460Trp with LV mass in Caucasians or African Americans; however, it
was associated with unfavorable LV geometry (higher RWT) in Caucasians and favorable LV geometry (lower RWT) in
African Americans after controlling for factors that would affect plasma volume.
Keywords: Adducin, genetic polymorphism, left ventricular mass, left ventricular geometry, hypertrophy

Introduction
Optimal functioning of the left ventricle requires
normal left ventricular (LV) mass and geometry.
Studies have shown that alteration in either LV
mass [1, 2] or geometry [3-5] leads to impairment in LV function. Reduction of LV systolic
function is associated with increased cardiovascular morbidity and mortality [6-10]. LV diastolic dysfunction is also a common correlate of
hypertension and other cardiovascular morbidities. Therefore, preserving normal LV mass and
geometry is an important clinical goal.
LV mass and geometry are, in part, under genetic influence, with heritability estimates for LV
mass as high as 0.59 [11]. Candidate gene

studies have reported statistically significant
associations between gene variants (e.g., in
TGFB1 [12], NPPA [13]) and LV hypertrophy as
well as between variants (e.g., in NPY2R,
SFPR2, IL15 [14]) and other structural phenotypes. The adducin 1 (alpha) gene (ADD1) encodes a cytoskeletal protein involved in cell to
cell contact [15], cell membrane transport [16],
signal transduction [17], and promoting assembly of spectrin-actin complexes. A mutation in
human ADD1 results in the substitution of tryptophan (Trp) for glycine ( Gly) at amino acid 460
(Gly460Trp, rs4961) [18]. Cusi et al. [18] have
shown that the ADD1 Gly460Trp polymorphism
is associated with elevated blood pressure,
plasma renin activity, and urinary tubular
sodium reabsorption. Urinary sodium is a major
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contributor to plasma volume [19, 20], and the
downstream effect of increased plasma volume
is higher blood pressure. The combination of
volume expansion and elevated blood pressure
can contribute to abnormalities of LV mass and
geometry.
In this cross-sectional study, we evaluated the
association between the ADD1 Gly460Trp polymorphism and LV size and geometry. Previous
studies have reported conflicting results regarding the association of this polymorphism with LV
mass [21, 22], but their small sample sizes and
differences in patient populations may explain
the variable results. The Hypertension Genetic
Epidemiology Network (HyperGEN) Study, with a
sample size of 3483 individuals, is adequately
powered to detect modest associations between the variant and echocardiographic LV
parameters.
Materials and methods
Sample
The HyperGEN Study is a part of the Family
Blood Pressure Program, designed to assess
the genetic basis of hypertension in populationbased samples. HyperGEN recruited three types
of subjects: first, a sample of severe and mild
hypertensive sibships with hypertension onset
before age 60 without type 1 diabetes or renal
failure; second, a random sample from the
same base populations from which normotensive controls for genetic association and epidemiological analyses could be drawn; the third
sample included the non-medicated adult offspring of the hypertensive siblings. The study
populations were ascertained through population cohorts (Atherosclerosis Risk in Communities Study; the National Heart, Lung and Blood
Institute Family Heart Study; and the Framingham Study). Hypertension was diagnosed according to treatment with one or more antihypertensive medications or average systolic
blood pressure (SBP) ≥140 mm Hg or average
diastolic blood pressure (DBP) ≥90 mm Hg from
two clinic visits. The Genetics of Left Ventricular
Hypertrophy Study is ancillary to HyperGEN and
performed echocardiograms in 4 HyperGEN
centers (Birmingham, AL; Forsyth County, NC;
Minneapolis, MN; Salt Lake City, UT). Detailed
information on study design and the recruitment
strategy can be found in Williams et al. [23].
This study was approved by the centers’ institu-
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tional review boards, and all subjects gave informed consent.
Echocardiographic methods and derived
variables
Echocardiograms were performed using a standardized protocol [24-26] with phased-array
echocardiograph with M-mode, 2-dimensional,
and color flow Doppler capability. The head of
the examining table was elevated 30°, and a
partial decubitus position was maintained. The
parasternal acoustic window was used to record
≥10 consecutive beats of 2D and M-mode readings of LV internal diameter and wall thickness
at or just below the mitral leaflet tips in long and
short-axis views, long axis view of the mitral
valve, color flow readings to search for mitral
and aortic regurgitation, and M mode and 2D
short- and long-axis views of the aortic root and
left atrium. The apical window was used to record ≥10 cycles of 2- and 4-chamber images
and color Doppler recordings to assess LV wall
motion and valvular regurgitation.
Correct orientation of planes for imaging and
Doppler recordings was verified according to
standard procedures. LV internal dimensions
and wall thickness were measured at end diastole and end systole according to American Society of Echocardiography recommendations
[25]. When optimal orientation of LV M-mode
readings could not be obtained, correctly oriented, linear, 2-dimensional measurements
were made. Wall motion was assessed in
parasternal long- and short-axis views and apical 2-, 3-, and 4-chamber views, with the left
ventricle divided into 5 segments at the base, 5
at the papillary muscles, and 4 at the apex [27].
Doppler LV outflow tract measurements identified inflow and outflow profiles simultaneously
for measurement of isovolumic reaction time
(IVRT) from the aortic closure spike to the onset
of mitral inflow. Echocardiographic measurements were made or confirmed by highly experienced physician investigators. All readers were
blinded to subjects’ clinical data.
LV mass was calculated using the anatomically
validated formula [24]:
0.80*1.04[(IVSTd+LVIDd+PWTd)-(LVID) 3 – (LVIDd) 3] +0.6

LV mass index (LVMI) was calculated as LV
mass/height2; LVMht2.7 was calculated as LV
mass/height2.7 [28]. Relative wall thickness
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(RWT) was calculated as twice the posterior wall
thickness/LV internal radius at end-diastole.
End-diastolic and -systolic LV volumes were calculated by the Teichholz method [29]. Myocardial contractile efficiency was assessed by examining the relation of midwall fractional shortening (MWS) to midwall circumferential end
systolic stress (cESS) measured at the level of
the LV minor axis [30-32]. MWS was calculated
considering the epicardial migration of the midwall during systole; cESS was estimated at the
midwall by the use of a cylindrical model [33].
MWS was expressed as a percent of the value
predicted from cESS using an equation derived
in normal subjects [30] and referred to as
stress-corrected MWS. As 60% of subjects had
diastolic filling measurements available at the
leaflet tips and the rest had these measurements available at the annulus, the following
equations were used to convert the diastolic
filling parameters at the leaflet tips when the
leaflet tip measurements were missing:
Eat tips=0.84×Eat annulus+23.3
Aat tips=0.76 × Aat annulus+28.9
deceleration timeat tips=0.56×deceleration timeat annulus+106

Accepted protocols were used to calculate other
echocardiographic measures of systolic and
diastolic performance.
Other clinical measures
Average blood pressure was calculated using
the second and third of three seated readings
using an oscillometric blood pressure monitor
(Dinamap 1846 SX/P; GE Healthcare, Waukesha, WI). Standardized assessments of body
mass index (BMI), blood chemistries, and a lipid
profile after a 12-hour fast were obtained. Diabetes was diagnosed by American Diabetes Association criteria (fasting blood glucose level
>126 mg/dl or use of hypoglycemic medication). An overnight urine sample was obtained
for urinary sodium; glomerular filtration rate
(GFR) was estimated by the abbreviated Modification of Diet in Renal Disease equation [34,
35].
Genotyping
The ADD1 Gly460Trp mutation was genotyped
using a restriction fragment length polymor-
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phism technique on polymerase chain reaction
(PCR) products that were amplified from isolated genomic DNA. PCR products were exposed to the restriction endonuclease Sau96 I,
and fragments were separated and identified
using gel electrophoresis. Genotyping methods
and quality control parameters for the method
have been reported in more detail previously
[36, 37].
Statistical methods
All statistical analyses were conducted using
SAS (version 9.1). Data are presented as
mean ± SD for continuous variables and as proportions for categorical variables. The Χ2 statistic was used to determine differences of categorical variables and to test for Hardy Weinberg
equilibrium; Student’s t-test was used to determine between-group differences of continuous
variables. Because of the low minor allele frequency, the ADD1 Gly460Trp genotypes were
grouped as GlyGly and GlyTrp+TrpTrp for primary analyses. For secondary analyses, associations of echocardiographic variables (EF, FS,
RWT) were also tested using the three genotypes. Comparison of means of echocardiographic measurements between genotype
groups (i.e., GlyGly versus GlyTrp+TrpTrp) was
made using one-way ANOVA in Caucasians and
African Americans separately. Bivariate models
of ADD1 genotype group with potential covariates (age, race, gender, BMI, total cholesterol,
high-density lipoprotein cholesterol (HDL-C), lowdensity lipoprotein cholesterol (LDL-C), urinary
sodium, GFR, DBP, SBP, presence of diabetes,
hypertension, antihypertensive medication use,
and smoking) were run, and those having more
than 10% change in beta coefficient for ADD1
genotype group were included in the final
model. An ANCOVA model was used to adjust for
potential confounding effects of these covariates. Potential interactions between the ADD1
genotype group and covariates with echocardiographic variables were also tested. Log transformation was applied to renin, atrial natriuretic
peptide, RWT, and MWS because of their
skewed distribution. LVMI, cardiac output, cardiac output/body surface area values three
times outside the interquartile range were deleted from all analyses. Tests of means across
genotypes groups also were performed with
mixed models, which adjust for the covariates
and also take into account familial structure.
Means of urinary sodium excretion and plasma
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Table 1. Demographic and clinical characteristics of subjects by race, prevalence or mean ± SD
Characteristics
Caucasians
African Americans
P value
(n=2004)
(n=1479)
Age, yrs
Women, %
Hypertension, % present
Diabetes, % present
Antihypertensive medication, % using
Current smoker, %
Body mass index, kg/m2
Systolic blood pressure, mm Hg
Diastolic blood pressure, mm Hg
Total cholesterol, mg/dl
Low density lipoprotein cholesterol, mg/dl
High density lipoprotein cholesterol, mg/dl
Urinary sodium, mmol/L
Adducin 1 (alpha), % with Trp allele

55.8 ± 12.9
52
65
14
58
45

47.8 ± 12.7
64
73
21
62
53

<.0001
<.0001
<.0001
<.0001
.0373
<.0001

29.3 ± 5.9
122.5 ± 19.9
68.3 ± 10.4
198.3 ± 37.5
118.0 ± 32.1
49.4 ± 14.8
98.5 ± 52.2
38

31.8 ± 7.5
128.7 ± 21.9
73.8 ± 11.5
195.6 ± 40.0
120.3 ± 37
53.7 ± 15.3
117.7 ± 60.6
17

<.0001
<.0001
<.0001
.0454
.0575
<.0001
<.0001
<.0001

Table 2. Trp allele frequency of adducin 1 (alpha) gene, stratified by center

Adducin 1 (alpha), % with Trp allele

MA

MN

UT

C
(n=561)

C
(n=518)

C
(n=730)

C
(n=195)

AA
(n=497)

AA
(n=982)

34

43

36

46

16

18

renin (data available for 919 subjects) were
compared between GlyGly and GlyTrp+TrpTrp
genotypes using ANCOVA adjusting for age, BMI,
SBP, and diabetes, stratified by race. Because
our dependant variables are strongly correlated,
Bonferroni correction would have been overly
conservative; therefore, we did not systematically apply multiple comparison criteria. Twotailed P values of <.05 were considered significant.
Results
Among 3483 study participants, 58% were Caucasian, 57% were female, and 60% were taking
antihypertensive medications. The distribution
of ADD1 Gly460Trp genotype in the study population was GlyGly, 71%; GlyTrp, 26%; and TrpTrp,
3%. Table 1 shows the demographic and clinical
characteristics of subjects, stratified by race.
The frequency of the Trp allele was higher in
Caucasians (38%) than African Americans
(17%), (P < .0001). African Americans were
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NC

AL

younger (mean age 48 ± 13 yr) than Caucasians
(mean age 56 ± 13 yr; P < .0001). A greater
proportion of African Americans had hypertension (73%) and diabetes (21%), with higher BMI
(32 ± 8 vs. 29 ± 6 kg/m2), systolic blood pressure (129 ± 22 vs. 123 ± 20 mm Hg), diastolic
blood pressure (74 ± 12 vs. 68 ± 10 mm Hg),
and urinary sodium (118 ± 61 vs. 99 ± 52
mmol/L) than Caucasians. Caucasians had
higher total cholesterol (198 ± 38 vs. 196 ± 40
mg/dL) but lower LDL-C and HDL-C than African
Americans. The distribution of the ADD1 Trp
allele by field center is shown in Table 2. The
distribution in each center and in the sample
overall were in Hardy-Weinberg equilibrium.
Table 3 shows the results of the 1-way ANOVA
comparing genotype groups with respect to
echocardiographic measurements, stratified by
race. In Caucasians the GlyTrp+TrpTrp genotype
group had higher EF, FS, and RWT than the GlyGly genotype. In contrast, in African Americans
the GlyTrp+TrpTrp genotype group had non-
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Table 3. Age adjusted means ± SD of echocardiograph measurements, stratified by race (1-way ANOVA)
Caucasians
(n=2004)
GlyGly

GlyTrp+TrpTrp

P*

African Americans
(n=1479)
GlyGly
GlyTrp+TrpTrp

P*

Structural variables
LVMI, g/m2

83.7 ± 0.6

83.2 ± 0.7

.6329

84.1 ± 0.7

82.9 ± 1.4

.4574

LVMht2.7, g/m2.7

40.2 ± 0.3

39.5 ± 0.4

.1649

40.8 ± 0.4

40.1 ± 0.8

.4324

RWT†

0.32 ± 0.004

0.33 ± 0.006

.0670

0.32 ± 0.005

0.31 ± 0.10

.0130

Systolic performance variables
Cardiac index

2577.8 ± 17.2

2596.6 ± 21.9

.5017

2695.3 ± 17.3

2660.5 ± 37.8

.4045

EF

61.5 ± 0.2

62.4 ± 0.3

.0249

61.1 ± 0.2

60.3 ± 0.5

.1103

ESV

51.1 ± 0.6

48.5 ± 0.8

.0113

51.9 ± 0.7

54.3 ± 1.5

.1477

FS

33.5 ± 0.2

34.1 ± 0.2

.0261

33.2 ± 0.1

32.7 ± 0.3

.1161

MWS†

4.7 ± 0.004

4.7 ± 0.005

.7857

4.7 ± 0.004

4.7 ± 0.008

.5951

Diastolic performance variables
IVRT, ms

82.3 ± 0.6

81.3 ± 0.7

.2277

78.4 ± 0.5

79.0 ± 1.0

.5541

MVA, cm/s

71.8 ± 0.6

72.1 ± 0.7

.7804

69.6 ± 0.6

69.4 ± 1.3

.8748

MVE, cm/s

75.9 ± 0.5

76.2 ± 0.7

.7546

78.5 ± 0.6

77.9 ± 1.2

.6773

MVE/MVA

1.13 ± 0.01

1.12 ± 0.02

.6019

1.21 ± 0.12

1.27 ± 0.04

.1417

LV, left ventricular; LVMI, LV mass/height2; LVMht2.7, LV mass/height2.7; RWT, relative wall thickness; EF, ejection
fraction; ESV, end systolic volume; FS, fractional shortening; MWS, stress corrected midwall shortening; IVRT, isovolumic reaction time; MVA, peak transmitral “A” velocity; MVE, peak transmitral “E” velocity.
*P values for F-test of means of means of corresponding echocardiographic measurements across the 2 genotypes.
†Natural log transformed data was used in ANOVA models.

statistically significant lower EF and FS but
higher RWT than the GlyGly genotype. None of
the other echocardiographic variables were associated with ADD1 genotype group in either
African Americans or Caucasians in the 1-way
ANOVA. Adjustment for additional potential confounding variables (DBP, SBP, GFR, smoking,
LDL-C, HDL-C, urinary sodium, and BMI) for
RWT, EF, and FS yielded virtually identical results (Table 4) for both the estimated means
and the associated P value.
Discussion
This study shows that the presence of the Trp
allele at position 460 of ADD1 is associated
with higher FS, EF, and RWT in Caucasians. In
contrast, African Americans with the Trp allele
showed no associations with either EF or FS but

371

had an association with reduced RWT relative to
the Gly homozygotes. There were no differences
between genotype groups for unadjusted LV
mass, LVMI, LVMht2.7, MWS, or diastolic parameters (isovolumic reaction time, peak transmitral E or A wave velocities, or the transmitral
E/A ratio) between the genotype groups in either Caucasians or African Americans.
The results of this study are in agreement with
those of Castellano et al. [21] which showed no
association of the ADD1 Gly460Trp polymorphism with LVMI (GlyGly, 96.5 ± 2.2; GlyTrp,
95.3 ± 4.9; TrpTrp, 108.5 ± 16.7), either before
or after adjusting for confounding factors. Like
our study, Castellano et al. also used a population-based sample with a genotype distribution
similar to our study (GlyGly, 74.8%; GlyTrp,
20.7%; TrpTrp, 4.5%). Our results differ from
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Table 4. Adjusted means (95% CI) in multivariate ANCOVA and mixed models, stratified by race
Caucasians

EF†
FS†
RWT‡

African American
value**

GlyGly

GlyTrp+TrpTrp

P value*

P

61.5
(61.05-61.9)
33.5
(33.2-33.8)
0.32
(0.32 -0.33)

62.4
(61.8-63.0)
34.1
(33.7-34.5)
0.33
(0.32- 0.33)

.0212

.0127

.0224

.0130

.0336

.0339

GlyGly
61.1
(60.7-61.6)
33.2
(32.9-33.5)
0.32
(0.31-0.32)

GlyTrp+Trp
Trp
60.2
(59.2-61.1)
32.5
(31.9-33.2)
0.31
(0.30-0.31)

P value*

P value**

.0788

.1305

.0871

.1543

.0222

.0282

EF, ejection fraction; FS, fractional shortening; RWT, relative wall thickness; *P value for multivariate ANCOVA models.; **P value for
mixed models; †Model adjusted for age, diastolic blood pressure, glomerular filtration rate, smoking, low density lipoprotein; ‡Model
adjusted for age, urinary sodium, body mass index, systolic blood pressure, smoking, high density lipoprotein, glomerular filtration
rate.

Winnicki et al.'s [22] which found a significant
association (P = .006) of LVMI with the
Gly460Trp polymorphism. However, their study
employed multivariate analysis and was considerably smaller than ours (n=162 vs. 3483) [22].
The study population also differed: Winnicki et
al. [22] studied mildly hypertensive Caucasian
men, while our study population comprised men
and women, Caucasians and African Americans,
and hypertensive and normotensive individuals.
Winnicki et al. [22] categorized genotype as
GlyGly, GlyTrp, and TrpTrp and found that LVMI
was only associated with the TrpTrp genotype,
while we compared GlyGly vs. GlyTrp+TrpTrp
genotype groups. Therefore, we performed a
secondary analysis that used the three unpooled genotypes. In Caucasians the associations with EF, FS, and RWT remained the same
as in the pooled analysis [EF (GlyGly,
61.5 ± 0.2;
GlyTrp,
62.3 ± 0.3;
TrpTrp,
63.6 ± 0.9; P = .02); FS (GlyGly, 33.5 ± 0.2;
GlyTrp, 34.0 ± 0.2; TrpTrp, 34.9 ± 0.6; P = .3);
and RWT (GlyGly, 0.332 ± 0.004; GlyTrp,
0.332 ± 0.006; TrpTrp, 0.339 ± 0.01; P = .08)].
Conversely in African Americans EF and FS did
not show significant associations in the comparable analysis, and RWT showed a marginal association (P = .04).
Changes in LV mass [38, 39] and geometry [3941] are important predictors of cardiovascular
events. LV hypertrophy (LVH) increases morbidity and mortality from myocardial infarction,
stroke, and congestive cardiac failure. Blood
pressure is an important contributor to LVH
[42]. Epidemiologic studies have shown that
both genetic and environmental factors [22, 4346] play a significant role in LVH. Adducin is a
cytoskeleton membrane protein, which pro-
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motes binding of spectrin and actin; these actinspectrin-based membrane proteins help to assemble integral membrane proteins and to couple them to cytoplasm proteins [47]. In the cell,
this interaction of cytoskeletal and membrane
proteins is essential for maintenance of cell
polarity [48, 49] and regulation of ion transport
[50, 51]. In vitro studies in rat kidney epithelial
cells transfected with Milan hypertensive strains
(MHS, missense mutations in α (F316Y) and β
(Q529R) subunits of adducin [21]) have a significant increase in Na-K pump activity at Vmax
and Na-K pump units compared with cells carrying the Milan normotensive strains [16]. MHS
also show an increase in enzymatic activity of
outer medulla Na-K ATPase. Decreased urinary
excretion of sodium causes an increase in intravascular volume which leads to an increase
in volume overload [18] resulting in a change in
LV geometry. Apart from this, the myocardium is
rich in adducin; therefore, a polymorphism in
this gene may have a direct effect on the myocardium [22].
Our study suggests an association in Caucasians between the Gly460Trp polymorphism
and increased RWT but no association with
measures of LV mass; this pattern (increased
RWT, normal LV mass) is also referred to as
concentric LV remodeling. Concentric remodeling is seen in groups with highest peripheral
resistance; the normal LV mass in concentric
remodeling reflects offsetting by volume underload of the effect of pressure overload [52]. In
the HyperGEN Study, Province et al. have shown
an association between higher blood pressure
and presence of the Trp allele (OR=1.55,
CI=1.03-2.34) in Caucasians [36]. No significant differences in urinary sodium excretion
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have been associated with the Trp allele [53];
however, alterations in urinary sodium excretion
have been associated with changes in plasma
volume. Therefore, the mechanisms whereby
the Trp allele raises blood pressure in a population, and how that leads to concentric remodeling as seen in our study population, needs further evaluation.
The presence of the Trp allele was not associated with any difference in MWS in either racial
group. MWS is a more direct measure of myocardial contractile function than ejection fraction [30]. MWS might be subnormal or normal in
the presence of normal or increased ejection
fraction with higher RWT (as seen in our Caucasian population). MWS gives a superior estimate of myocardial function compared to EF
especially in the presence of abnormal left geometry as indicated by increases in RWT in our
study. Diastolic parameters (isovolumic relaxation time, mitral E and A velocities, and E/A ratio) did not differ across the genotype groups.
These may be affected early in development of
LV hypertrophy [38, 39, 54]; as LV mass did not
differ across genotype groups, lack of
Gly460Trp association with these parameters is
not surprising.
The Trp allele was associated positively with
RWT in Caucasians but negatively in African
Americans. The lower RWT in African Americans
with the Trp allele might reflect lack of association of the allele with blood pressure [55], since
previous HyperGEN studies have shown the Trp
allele to have a protective effect against hypertension traits in African Americans [36]. However, when we analyzed genotype specific differences in RWT in African Americans, we found
that heterozygotes had the lowest RWT of all
three genotypes (P < .04).
This study has important strengths, including
population-based recruitment, standardized
blood pressure and laboratory measurements, a
large sample that included women and men
and Caucasians and African Americans, as racial differences in ADD1 associations have been
described [36]. Second, we accounted for several clinical and demographic factors that have
been shown to influence LV size and function
[6, 31, 42]. This study also has limitations. Like
all cross-sectional studies, ours provides evidence of association but cannot evaluate the
temporality of the relationship. Because most
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hypertensive participants in our study were taking antihypertensive medications, our findings
may have been confounded by medication use.
We did not take into account multiple testing,
which may increase the probability of a false
positive finding; however the Bonferroni correction for multiple testing assumes independence
and, therefore, would have been an overcorrection since our dependent variables are strongly
correlated. Although there was a consistency of
the gene-phenotype association within the systolic function domain, suggesting that our findings are likely real, marginally significant associations should be interpreted with care.
In summary, our study found no association
between the ADD1 Gly460Trp variant and
measures of LV mass. However, the Trp allele
was associated with increased RWT and concentric remodeling in Caucasians and decreased RWT and favorable LV geometry in African Americans. Future genetic studies might
find it opportune to examine ADD1 Gly460Trp
associations with LV structure and function in
normotensive populations. Molecular studies
may illuminate whether this polymorphism influences the myocardium directly or whether observed associations are a function of blood
pressure and plasma renin activity.
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